Editorial comment on: “The development and validation of a prediction tool for chemotherapy-induced anemia in patients with advanced non-small cell lung cancer receiving palliative chemotherapy”. by Vincent et al.

By Korte Wolfgang  

Supportive Care in Cancer, Vol. 15, Iss. 3, 2007-03 ,pp. : 239-241

Springer Publishing Company

Access to resources Recommend Favorite

Quality of life in advanced non-small cell lung cancer patients receiving palliative chemotherapy: A meta-analysis of randomized controlled trials

By      

Experimental and Therapeutic Medicine, Vol. 3, Iss. 1, 2012-01 ,pp. : 134-140

Spandidos Publications

Access to resources Recommend Favorite

Expression of RRM1 and RRM2 as a novel prognostic marker in advanced non-small cell lung cancer receiving chemotherapy

By Wang Lei   Meng Long   Wang Xing-wen   Ma Guo-yuan   Chen Jing-han  

Tumor Biology, Vol. 35, Iss. 3, 2014-03 ,pp. : 1899-1906

Springer Publishing Company

Access to resources Recommend Favorite

A prospective study of the efficacy of a combination of autologous dendritic cells, cytokine-induced killer cells, and chemotherapy in advanced non-small cell lung cancer patients

By Zhong Runbo   Han Baohui   Zhong Hua  

Tumor Biology, Vol. 35, Iss. 2, 2014-02 ,pp. : 987-994

Springer Publishing Company

Access to resources Recommend Favorite

Quality of life and survival in patients with advanced non-small cell lung cancer receiving supportive care plus chemotherapy with carboplatin and etoposide or supportive care only. A multicentre randomised phase III trial

By Helsing M.   Bergman B.   Thaning L.   Hero U.  

European Journal of Cancer, Vol. 34, Iss. 7, 1998-06 ,pp. : 1036-1044

Elsevier

Access to resources Recommend Favorite